ZFIN ID: ZDB-EXP-210317-6 |
Experiment Conditions Description: chemical treatment by gavage: isotretinoin, chemical treatment by injection: doxorubicin
chemical treatment by gavage: isotretinoin |
---|
Name: | chemical treatment by gavage |
---|---|
Synonyms: | |
Definition: | Chemical treatment condition where the chemical is introduced to the organism by gavage. |
Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000255] |
Name: | isotretinoin |
---|---|
Synonyms: | (2Z,4E6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid, (7E,9E,11E,13Z)-retinoic acid, 13-cis-retinoic acid, 13-cis-Vitamin A acid, 13-RA, Accutane, Amnesteem, cis-RA, Claravis, isotretinoin, isotretinoina, isotretinoine, isotretinoino, isotretinoinum, Neovitamin A acid |
Definition: | A retinoic acid that is all-trans-retinoic acid in which the double bond which is alpha,beta- to the carboxy group is isomerised to Z configuration. A synthetic retinoid, it is used for the treatment of severe cases of acne and other skin diseases. |
Ontology: | ChEBI [CHEBI:6067] ( EBI ) |
chemical treatment by injection: doxorubicin |
---|
Name: | chemical treatment by injection |
---|---|
Synonyms: | |
Definition: | Chemical treatment in which the chemical is injected into the zebrafish. |
Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000237] |
Name: | doxorubicin |
---|---|
Synonyms: | (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, (1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, (8S-cis)-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione, 14-hydroxydaunomycin, 14-hydroxydaunorubicine, Adriamycin, doxorubicin, doxorubicine, doxorubicinum |
Definition: | |
Ontology: | ChEBI [CHEBI:28748] ( EBI ) |
Publication: | Ma et al., 2020 |
---|